天美传媒

Abstract

Cervical cancer prevention is evolving through advanced screening methods and improved access. Key developments include the effectiveness of HPV self-sampling and primary HPV testing, offering superior sensitivity and broader reach. Artificial Intelligence and digital colposcopy enhance diagnostic accuracy. While HPV vaccination programs reduce infection rates, significant challenges persist in screening uptake, follow-up adherence, and equitable access, especially in low-resource settings. Understanding women’s perceptions is crucial to overcome these barriers. Addressing these multifaceted issues requires innovative strategies and targeted interventions for global impact.